Intravitreal Ranibizumab in Retinal Pigment Epithelial Detachments
NCT00976222
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Pigment Epithelial Detachment
Interventions
DRUG:
intravitreal injection with ranibizumab
Sponsor
University Hospital Muenster
Collaborators
[object Object]